This funding record is inactive. Please see the program website or contact the program sponsor to determine if this program is currently accepting applications or will open again in the future.
Improving Access to Overdose Treatment (OD Treatment Access)
Application Deadline: Jun 4, 2018
Substance Abuse and Mental Health Services Administration (SAMHSA)
Awards funding to Federally Qualified Health Centers (FQHC), opioid treatment programs, or practitioners with waivers to prescribe buprenorphine to expand access to drugs and devices, approved by the U.S. Food and Drug Administration (FDA), for emergency treatment of known or suspected opioid overdose. Develops best practices for prescribing and co-prescribing overdose reversal drugs at the community level by partnering with other prescribers. Helps reduce the number of opioid-related overdose deaths and adverse events by utilizing the Substance Abuse and Mental Health Services Administration (SAMHSA) Opioid Overdose Prevention Toolkit to train and provide resources for healthcare providers and pharmacists on the prescribing of overdose drugs and devices in key community sectors as well as individuals who support persons at high risk for overdose. Establishes protocols to connect patients who have experienced a drug overdose with appropriate treatment, including medication-assisted treatment (MAT) and appropriate counseling and behavioral therapies.
Program activities include:
- Establishing a program for prescribing a drug or device approved or cleared under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose
- Training and providing resources for healthcare providers and pharmacists on the prescribing of approved overdose drugs or devices
- Establishing protocols to connect patients who have experienced a drug overdose with appropriate treatment, including MAT, and appropriate counseling and behavioral therapies
- Using SAMHSA's Opioid Overdose Prevention Toolkit as a guide to develop and implement a comprehensive prevention program to reduce the number of prescription drug/opioid overdose-related deaths and adverse events
- Addressing overdose by patients on prescribed opioids, focusing on potential drug interactions, reduction in dose, and evaluation for other substance issues such as alcohol use disorders
- Purchasing drugs or devices approved or cleared under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose, for distribution under the program
- Offsetting the co-payments and other cost sharing associated with approved overdose drugs or devices
Amount of Funding
Award ceiling: $200,000
Project period: Up to 5 years
Estimated number of awards: 5
Estimated total program funding: $940,000
Who Can Apply
Applications may be submitted by:
- Federally Qualified Health Centers (FQHCs) as defined in section 1861(aa) of the Social Security Act
- Opioid treatment programs as defined under part 8 of title 42, Code of Federal Regulations
- Practitioners dispensing narcotic drugs pursuant to section 303(g) of the Controlled Substances Act
Recipients who received Improving Access to Overdose Treatment (SP-17-006) funding in 2017 are not eligible to apply.
What This Program Funds
Capacity Building • New Program • Operating Costs and Staffing • Training Providers
Application instructions, requirements, and other information about the online application process can be found in the funding announcement.
For programmatic or technical
Tonia F. Gray, MPH
Kim Nesbitt, MA
For grants management or budget
Past awards communities have received are described on the program website.
One rural community who received funding is Preferred Family Healthcare, Incorporated in Kirksville, Missouri. A 2018 SAMHSA OD Treatment Access Grant was awarded to help Adair County respond to a spike in drug overdoses in Northeast Missouri.
Topics This Program Addresses
Emergency Planning • Harm Reduction • Healthcare Workforce • Medication-Assisted Treatment (MAT) • Mental Health • Naloxone • Opioids • Overdose Prevention • Substance Use Disorder • Treatment